Sanofi

SNYleader

Sanofi is a French multinational pharmaceutical company anchored by blockbuster biologic Dupixent (co-developed with Regeneron) and one of the world's largest vaccine businesses.

⇄ Compare

Produkte & Umsatz

Umsatzanteil nach Produkt

Umsatzaufschlüsselung ($46.1B)

Statische Daten (Echtzeitfinanzen werden geladen…)

Biopharma (55%)

Vaccines (18%)

General Medicines (18%)

Consumer Healthcare (9%)

Segmentzusammensetzung und Hauptkunden

Produktdetails

Dupixent30%

Blockbuster biologic for atopic dermatitis, asthma, and other inflammatory conditions

Vaccines (Sanofi Pasteur)20%

Flu vaccines, pediatric combinations, and Beyfortus (RSV)

General Medicines30%

Lantus insulin, Plavix, and mature drug portfolio

Specialty Care & Consumer20%

Rare disease treatments and consumer healthcare

Lieferkettenbeziehungen

Partner

Regeneron Pharmaceuticals

Dupixent co-development and profit sharing

Auswirkung: Critical — Regeneron develops key drug

Wettbewerber

Pfizer Inc.

Vaccines and respiratory

Auswirkung: Medium — vaccine market competition

AstraZeneca

Respiratory and immunology

Auswirkung: Medium — overlapping therapeutic areas

Makro- und Marktkontext

제약 / 바이오Sektornachrichten

GLP-1 메가트렌드 + AI 신약개발 + 저평가 바이오 기관 매집

GLP-1 시장 규모 (2030E)

$150B

mRNA 암백신 임상 성공률

+49% 재발 위험 감소

AI 신약개발 단계

임상 2상 진입

PFE/MRNA 52주 변화

-30% ~ -45%

Nächste Katalysatoren

◆LLY Orforglipron(경구용 GLP-1) 3상 결과 (2026.Q2)◆MRNA 암백신 FDA BLA 제출 예정◆REGN EYLEA HD 유럽 허가 결과

Aktuelle Nachrichten

Nachrichten laden...

KI-Analyse

Klicken Sie auf "KI-Analyse abrufen" für eine KI-gestützte Lieferkettenanalyse von Sanofi.

Unternehmensinformationen

Hauptsitz

Paris, France

Gegründet

2004

Mitarbeiter

91,000+

Website

sanofi.com

Sektorübersicht — 제약 / 바이오

Sektornachrichten